Scientists search for gut clues to cancer treatment success
NCT ID NCT04566029
Summary
This study aimed to understand why some patients with advanced bladder cancer respond well to immunotherapy while others do not. Researchers analyzed stool and blood samples from 40 patients to see if differences in their gut bacteria could predict treatment success. The goal was to gather knowledge that could one day help doctors better match patients with effective treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Leon Berard
Lyon, 69373, France
-
HEGP GH Universitaire Paris Ouest
Paris, 75908, France
-
Hopital Tenon ( Paris)
Paris, Paris Cx 20, 75970, France
-
ICANS Strasbourg
Strasbourg, 67091, France
-
ICM parc euromedecine
Montpellier, Hérault, 34298, France
-
ICO-Site Paul Papin
Angers, 49055, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Sainte Cancerologie Lucien Neuwirth
Avignon, Saint Priest En Jarez, 42271, France
-
Iuct Oncopole
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.